The intravenous access devices market is expanding due to the increasing demand for efficient and safe intravenous (IV) therapies across various healthcare settings. Intravenous devices are essential for administering fluids, medications, blood products, and nutrition, especially for patients in critical care, hospitals, and ambulatory surgery centers. The market is driven by the rising prevalence of chronic diseases, an aging population, and a surge in the need for surgical procedures requiring IV access. In addition, advancements in technology are significantly improving the design and safety features of IV devices. For instance, the development of needle-free blood collection systems such as BD's PIVO Pro and innovations in safety IV catheters, such as B. Braun's Introcan Safety 2, help minimize the risk of needle-stick injuries and prevent exposure to bloodborne pathogens. Furthermore, companies are focusing on improving the functionality of IV catheters, with features such as multi-access blood control and dual-lumen catheters. The integration of smart technologies, such as connected infusion pumps, is enhancing patient safety and reducing medical errors. As healthcare infrastructure improves globally, especially in emerging regions, the intravenous access devices market is expected to see substantial growth in the coming years.
